Tag: Rheumatoid arthritis
Fragment-based design of isoquinoline derivatives as anti-inflammatory drugs
Fragment-based drug discovery (FBDD) is a well-established high-throughput screening method for drug generation. Fragment molecules used in FBDD tend to be structurally less complex than the compounds used in conventional high-throughput screening techniques. Dr Masakazu Atobe from Asahi Kasei Pharma Corporation in Japan and his colleagues have developed a methodology that can be applied to the discovery of effective drugs […]
The role of CD83: Autoimmunity, transplantation and beyond
Professor Alexander Steinkasserer is based at the Department of Immune Modulation, University Hospital, Erlangen. His research interests are focused on the immune system, with the long-term aim to develop new therapeutic strategies for patients suffering from autoimmune disorders or in need of transplantation. Along with his colleagues at the department of Immune Modulation, Professor Steinkasserer has shed much light on […]
Case for the improvement of suboptimal care of gout patients in Hawai’i
The level of care for gout patients in Hawai’i has been a subject of concern to stakeholders. A retrospective study of gout and rheumatoid arthritis patients who were 18 years and above within Hawai’i Pacific Health healthcare system between 2011 and 2017 were undertaken by Dr Sian Yik Lim MD, CCD, Rhmsus, a Doctor of Medicine, Pali Momi Medical Center, […]
Therapeutic drug monitoring of methotrexate in disease
Professor Dr Robert de Jonge, Dr Gerrit Jansen, Ittai Muller MSc and Helen Gosselt MSc, Amsterdam University Medical Center, are pioneering analytical approaches which can be used to understand why patients respond differently to the anchor drug used to manage rheumatoid arthritis, called methotrexate. Their work has begun to unravel the key factors behind the mechanism of action of methotrexate, […]